Puretech's lyt-100 (deupirfenidone) achieves 50% reduction in healthy older adults experiencing gi-related adverse events compared to pirfenidone

Boston--(business wire)--puretech's lyt-100 (deupirfenidone) achieves 50% reduction in healthy older adults experiencing gi-related adverse events compared to pirfenidone

PRTC Ratings Summary

PRTC Quant Ranking